Stefano Pessina: Alliance Boots’ Growth and Healthcare Leadership

Stefano Pessina has had a profound effect on healthcare systems and economies around the globe with his companies, creating strategic partnerships and funding innovative projects which have significantly altered business.

Pessina launched his pharmaceutical wholesaler business with his family in 1977 and later merged it with Boots pharmacy chain in 2006. Alliance Boots was taken private through a $22 billion transaction with KKR in 2012. Walgreens then acquired it.

Innovation

As the global leader in pharmacy-led health and beauty retailing, Alliance Boots has achieved tremendous success through innovation. The company continually implements new technologies across its businesses in order to enhance customer experiences, gain competitive advantages, and boost revenues – such as new delivery models that help patients access healthcare more easily.

With an agile team in place, the company is able to quickly turn ideas into viable solutions for its customers – helping to increase customer lifetime value. One such example of this process is its Beauty Incubator which transforms first-party data insights into powerful personal experiences for its users. Furthermore, its collaborative design approach enables fast and informed decisions regarding which innovations will provide maximum benefit to each of its customers.

The company invests in innovation through partnerships, ventures, and research and development (R&D). For instance, it works closely with startups to develop an online platform allowing patients to manage their prescriptions more efficiently; and is working on creating wearable devices to monitor blood pressure. Furthermore, they collaborate with a medical research institute on developing treatments for diabetes and inflammatory conditions.

Alliance Boots has an acclaimed legacy of innovation; however, it currently faces numerous obstacles. Notably, market share in US drugstore business has declined and been heavily criticised by protest groups such as UK Uncut; furthermore, high interest rates are due on multibillion-pound debts that it owes.

Due to these factors, CVS Caremark is struggling to return to profitability, with stock prices suffering due to uncertainty regarding a full merger between CVS Caremark and Walgreens. But the company remains committed to creating sustainable value for shareholders through creating sustainable strategies.

The company is working to reduce overheads in order to free up more resources for innovation and customer service, such as cutting headcount by 9,000 over two years; this will save approximately PS400m; they also plan on moving their headquarters from London to Switzerland which should reduce expenses by around PS250m.

Partnerships

Walgreens Boots Alliance (WBA), as one of the world’s largest drugstore chains, has no plans to sit on its laurels as the world’s most successful pharmacy chain. Instead, WBA is seeking growth by forging partnerships within and beyond healthcare. At a recent Forbes Healthcare Summit event hosted by Forbes Media LLC, CEO Stefano Pessina discussed WBA’s partnership with Kroger as well as work done with VillageMD, an organization providing primary care clinics.

Kroger is one of many examples of business-to-business partnerships guiding the company’s future strategy, featuring an innovative store format which combines retail with pharmacy offerings at an attractive price. Furthermore, this store also provides health screenings and prescription fulfillment.

WBA is also proud of their work with Verily, a Silicon Valley start-up that creates wearable technology for healthcare, in developing digital health solutions and new consumer interactions with healthcare providers. This partnership represents an expansion of an already long-standing relationship and underscores WBA’s desire to increase its presence within this field.

At AmerisourceBergen, the same approach is taken. Both companies have joined forces to expand access to generics and other pharmaceuticals across communities nationwide, and reduce costs at both. Furthermore, this partnership may make competing more cost effectively in the pharmaceutical wholesale market easier for both parties involved.

At its heart, this partnership between businesses aims to assist patients and their families navigate the often complicated world of pharmaceuticals and healthcare. By joining forces, both will provide greater value for patients as well as their shareholders.

Pessina and his team face an exciting future; his company is in the midst of downsizing 300 stores within one year in the UK as part of an initiative to right size itself, along with closing pharmacies which are too close together or have low customer footfall.

Philanthropy

Walgreens Boots Alliance (WBA) is the world’s first pharmacy-led health and wellness company, founded on a mission of helping people around the world live more fully. WBA strives to innovate while creating value through strategic combinations of its retail pharmacy, healthcare services, pharmaceutical wholesaling/distribution capabilities and brand product offerings.

In the US, Boots operates over 8,000 stores and provides services such as home delivery and prescription filling for patients. As a leading innovator in consumer health and beauty care as well as local clinical care. Meanwhile in the UK it serves as a major retailer of healthcare products and services; one such brand being Boots which dates back 160 years in UK high streets; pharmacy ownership as well as owning UK wholesaler Allied Healthcare who supply medicine to over 110,000 pharmacies, hospitals, and health centers nationwide.

Growth at this company has been driven by both acquisitions and organic expansion in retail business. Acquisitions included US drugstore chains Duane Reade and Rite Aid in 2010 and 2014 respectively; as part of KKR’s control in 2007 transaction, delisting from London Stock Exchange and relocation to Switzerland took place as a consequence. Although some groups such as UK Uncut criticised this move for tax reasons only.

WBA’s leadership has an established record of successfully creating and driving commercially viable initiatives, businesses, and partnerships to enhance patient outcomes while simultaneously lowering costs and opening new models of healthcare delivery. This includes senior roles at payer organizations, retail healthcare services providers, providers and providers such as VillageMD; as well as serving successfully as CEO. Mary Langowski will serve as Executive Vice President and President, U.S. Healthcare for WBA; she will oversee all provider and at-home care assets within this division.

Leadership

Stefano Pessina has made a tremendous mark on the pharmaceutical industry. Through his leadership and innovation, his company has expanded into new markets. Additionally, he has formed strategic alliances with key players from retail and healthcare industries that have fostered growth while driving innovation within his organization – positioning Pessina Pharmaceutical as an industry leader.

Pessina’s success as CEO lies in creating an organization with a diverse workforce and strong culture, creating programs to assist employees with career growth as well as initiatives promoting health and wellness in the workplace. His dedication to corporate social responsibility has attracted top talent while improving business results.

Stefano Pessina quickly established a stellar track record as an innovative entrepreneur upon taking over his family’s pharmaceutical wholesaling business, quickly turning it into one of Europe’s premier drugstore chains and operating across multiple countries worldwide.

Pessina’s innovative strategies and visionary leadership have had a profound effect on global economies and healthcare systems. His focus has been to produce high-performing products which are safe and effective while advocating for new avenues of innovation; furthermore, his support of research is unwavering – his dedication to technological advances fueling his companies’ expansion and success.

He has always placed great emphasis on giving back to the community and is actively involved in philanthropy efforts. He has donated to numerous educational and healthcare-oriented charities. Furthermore, he has invested in several new ventures designed to capitalize on evolving trends within healthcare and retail industries.

Pessina led the successful merger between Walgreens and Alliance Boots in 2014. Together, this combined company currently boasts around 9,000 stores with revenue surpassing $139 billion. His wealth mainly stems from his 16.8% stake in this Deerfield, Illinois-based company held through Luxembourg-based holding companies Alliance Sante Participations and NewCIP II which ultimately belong to his family trust.